source
- Eli Lilly's 2026 acquisitions boost over 50 biotech venture investorsEli Lilly announced its thirteenth acquisition of 2026, continuing a busy year of dealmaking for the drugmaker. The transactions have involved at least fifty different venture capital firms, sendi…
- Trump administration announces new drug pricing pledges, but details remain undisclosedOn Monday the Trump administration said a second group of pharmaceutical companies had agreed to cut drug prices to levels similar to those in other countries. The companies involved have pledged t…